Loading...
CEL-SCI Corporation
CVM•AMEX
Healthcare
Biotechnology
$3.51
$0.71(25.36%)
CEL-SCI Corporation (CVM) Financial Performance & Statements
Review CEL-SCI Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
16.28%
↑ 16.28%
Net Income Growth
16.82%
↑ 16.82%
Operating Cash Flow Growth
17.67%
↑ 17.67%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-1.00%
↓ 1.00%
ROIC
-0.12%
↓ 0.12%
CEL-SCI Corporation (CVM) Financial Statements
Explore quarterly and annual reports for CEL-SCI Corporation stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $991580.00 | $983208.00 | $988762.00 |
| Gross Profit | $0.00 | -$991580.00 | -$983208.00 | -$988762.00 |
| Gross Profit Ratio | ||||
| R&D Expenses | $4.43M | $4.48M | $4.70M | $4.63M |
| SG&A Expenses | $2.46M | $1.64M | $1.97M | $1.46M |
| Operating Expenses | $5.90M | $6.12M | $6.67M | $6.09M |
| Total Costs & Expenses | $6.89M | $6.12M | $6.67M | $7.08M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $170103.00 | $174571.00 | $190705.00 | $182701.00 |
| Depreciation & Amortization | $995192.00 | $991580.00 | $984208.00 | $988762.00 |
| EBITDA | -$5.91M | -$4.94M | -$5.68M | -$6.07M |
| EBITDA Ratio | ||||
| Operating Income | -$6.89M | -$6.12M | -$6.67M | -$7.08M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$179644.00 | $10912.00 | -$186323.00 | -$168943.00 |
| Income Before Tax | -$7.07M | -$6.11M | -$6.86M | -$7.24M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$2.00 |
| Net Income | -$7.07M | -$6.11M | -$6.86M | -$7.24M |
| Net Income Ratio | ||||
| EPS | -$0.11 | -$0.11 | -$0.14 | -$0.14 |
| Diluted EPS | -$0.11 | -$0.11 | -$0.14 | -$0.14 |
| Weighted Avg Shares Outstanding | $65.33M | $54.04M | $53.99M | $52.006M |
| Weighted Avg Shares Outstanding (Diluted) | $65.33M | $54.04M | $53.99M | $52.006M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan